Meta-Analysis of Efficacy of Interventions for Elevated Depressive Symptoms in Adults Diagnosed With Cancer

Department of Psychology, University of California Los Angeles, CA 90095-1563, USA.
Journal of the National Cancer Institute (Impact Factor: 12.58). 07/2012; 104(13):990-1004. DOI: 10.1093/jnci/djs256
Source: PubMed


Cancer patients are at increased risk for depression compared with individuals with no cancer diagnosis, yet few interventions target depressed cancer patients.
Efficacy of psychotherapeutic and pharmacologic interventions for depression in cancer patients who met an entry threshold for depressive symptoms was examined by meta-analysis. Five electronic databases were systematically reviewed to identify randomized controlled trials meeting the selection criteria. Effect sizes were calculated using Hedges' g and were pooled to compare pre- and postrandomization depressive symptoms with a random effects model. Subgroup analyses tested moderators of effect sizes, such as comparison of different intervention modalities, with a mixed effects model. All statistical tests were two-sided.
Ten randomized controlled trials (six psychotherapeutic and four pharmacologic studies) met the selection criteria; 1362 participants with mixed cancer types and stages had been randomly assigned to treatment groups. One outlier trial was removed from analyses. The random effects model showed interventions to be superior to control conditions on reducing depressive symptoms postintervention (Hedges' g = 0.43, 95% confidence interval = 0.30 to 0.56, P < .001). In the four psychotherapeutic trials with follow-up assessment, interventions were more effective than control conditions up to 12-18 months after patients were randomly assigned to treatment groups (P < .001). Although each approach was more effective than the control conditions in improving depressive symptoms (P < .001), subgroup analyses showed that cognitive behavioral therapy appeared more effective than problem-solving therapy (P = .01), but not more effective than pharmacologic intervention (P = .07).
Our findings suggest that psychological and pharmacologic approaches can be targeted productively toward cancer patients with elevated depressive symptoms. Research is needed to maximize effectiveness, accessibility, and integration into clinical care of interventions for depressed cancer patients.

Download full-text


Available from: Bonnie Spring, Dec 22, 2013
  • Source
    • "Meta-analyses of psychotherapies are strongly biased toward concluding that treatments work, especially when conducted by those who have undeclared conflicts of interest and investigator allegiances. This includes developers and promoters of treatments that stand to gain financially or otherwise from their branding as " evidence-supported " (e.g., Hayes, Luoma, Bond, Masuda, & Lillis, 2006; Johnson, Hunsley, Greenberg, & Schindler, 2006; Nowak & Heinrichs, 2008; Sanders, Kirby, Tellegen, & Day, 2014), as well as meta-analyses organized by professional organizations (Hart et al., 2012) intent on demonstrating the availability of evidence supported treatments for dissemination and reimbursement (Coyne, 2012). Overall, meta-analyses too heavily depend on underpowered, flawed studies conducted by investigators with strong allegiances to a particular treatment or to finding that psychotherapy is in general efficacious. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recognition of the unreliability of findings in the biomedical literature, and especially pharmaceutical trials has led to a number of reforms. These include reporting preregistration of protocols for clinical trials and meta-analysis, reporting standards and making data available to others for all clinical trials, as well as recognition of the influence of conflicts of interest. These improvements are only partially and inconsistently reflected in the literature evaluating psychotherapies. The psychotherapy literature is currently of too poor quality to provide a reliable guide to clinicians, consumers, and policymakers. The literature is dominated by underpowered trials with high risk of bias producing positive effects at a statistically improbable rate. Meta-analyses that are poorly conducted with undisclosed conflicts of interest compound these problems. A number of reforms are proposed. These include accelerating adoption of those already occurring in the pharmaceutical literature. Additionally, psychotherapy research should parallel the orderly sequence of treatment development seen in the pharmaceutical literature. Phase III trials providing the effect sizes of treatments should not be conducted until the acceptability of treatment and the feasibility of accruing sufficient numbers of patients are established. The role of investigator allegiance as a potential and potent source of conflict of interest needs to be recognized. Yet, enforcement of existing standards could counter many of the deficiencies of the current literature, but such enforcement may only come with pressures emanating from outside the field of psychotherapy.
    Full-text · Article · Sep 2014
  • Source
    • "If this potentially treatable condition is recognized, the treatment usually consists of the combination of antidepressants and intensive psychological treatment, such as cognitive behavioral therapy (CBT) [24,25]. Both pharmacological and psychological treatment can encounter problems in glioma patients specifically. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Among glioma patients, depression is estimated to be more prevalent than in both the general population and the cancer patient population. This can have negative consequences for both patients and their primary informal caregivers (e.g., a spouse, family member or close friend). At present, there is no evidence from randomized controlled trials for the effectiveness of psychological treatment for depression in glioma patients. Furthermore, the possibility of delivering mental health care through the internet has not yet been explored in this population. Therefore, a randomized controlled trial is warranted to evaluate the effects of an internet-based, guided self-help intervention for depressive symptoms in glioma patients.Methods/design: The intervention is based on problem-solving therapy. An existing 5-week course is adapted for use by adult glioma patients with mild to moderate depressive symptoms (Center for Epidemiology Studies Depression Scale score >=12). Sample size calculations yield 126 glioma patients to be included, who are randomly assigned to either the intervention group or a waiting list control group. In addition, we aim to include 63 patients with haematological cancer in a non-central nervous system malignancy control group. Assessments take place at baseline, after 6 and 12 weeks, and after 6 and 12 months. Primary outcome measure is the change in depressive symptoms. Secondary outcome measures include health-related quality of life, fatigue, costs and patient satisfaction. In addition, all patients are asked to assign a primary informal caregiver, who does not participate in the intervention but who is asked to complete similar assessments. Their mood, health-related quality of life and fatigue is evaluated as well. This is the first study to evaluate the effects of problem-solving therapy delivered through the internet as treatment for depressive symptoms in glioma patients. If proven effective, this treatment will contribute to the mental health care of glioma patients in clinical practice.Trial registration: Netherlands Trial Register NTR3223.
    Full-text · Article · Apr 2014 · BMC Neurology
  • Source
    • "Over 15 years of clinical trials, collaborative depression care not only enhances adherence to either depression treatment adherence but also significantly improves depressive symptoms (Bao et al., 2011; Interian, Lewis-Fernández, & Dixon, 2013; Katon, Unützer , et al., 2010; Katon et al., 1999; Katon, Lin, et al., 2010; Katon et al., 2004). Other types of care for depression among cancer patients demonstrated better disease outcomes and self-reported quality of life in an intervention group (Andersen et al., 2004; Antoni et al., 2001; Kissane et al., 2007; Hart et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: This study assessed whether perceived social support (PSS) is a factor in improving physical and functional well-being observed among cancer patients receiving collaborative depression care. Methods: A secondary analysis was conducted of data collected in a randomized clinical trial testing the effectiveness of collaborative depression care. PSS was measured at 12 months; physical and functional well-being were assessed at 18 and 24 months post-baseline. Mediation analyses via a bootstrapping method were conducted. Results: Significant mediation of PSS at 12 months predicted better physical and functional well-being at 18 months and 24 months. Conclusion: Depressed cancer survivors are likely to benefit when social workers provide psychosocial depression care aimed at activating social support, thereby improving physical and functional well-being.
    Full-text · Article · Feb 2014 · Research on Social Work Practice
Show more